The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions
Endometriosis is associated with increased microvessel density and VEGF-A expression in eutopic endometrium and endometriotic lesions, particularly in those with high proliferative activity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (52)
- Angiogenesis: a new theory for endometriosis via openalex
- Angiogenesis in endometriosis via openalex
- Angiogenic factors in endometriosis via openalex
- Aromatase expression in endometriosis via openalex
- Cell proliferation is increased in the endometrium of women with endometriosis via openalex
- Endometriosis: current concepts and therapy via openalex
- Heritability and candidate genes for endometriosis via openalex
- Higher activity by opaque endometriotic lesions than nonopaque lesions via openalex
- Immunohistochemical analysis of CA125, CA19‐9, and Ki‐67 in stage III or IV endometriosis: via openalex
- Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation via openalex
- Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium via openalex
- Immunolocalisation of vascular endothelial growth factor in human endometrium via openalex
- Immunology and endometriosis via openalex
- Is mild endometriosis a progressive disease? via openalex
- Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis via openalex
- Morphometric study of the stromal vascularization in peritoneal endometriosis via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Short-term culture of peritoneum explants confirms attachment of endometrium to intact peritoneal mesothelium via openalex
- The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium via openalex
- The epidemiology of endometriosis via openalex
- Theories of endometriosis via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia via openalex
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids via openalex
- W2098736824 via openalex
- W1584635482 via openalex
- W1985959551 via openalex
- W2011590093 via openalex
- W2013631219 via openalex
- W2050499474 via openalex
- W2057684012 via openalex
- W2060293761 via openalex
- W2068720272 via openalex
- W2077601824 via openalex
- W2092174240 via openalex
- W2093303434 via openalex
- W606624214 via openalex
- W2140246703 via openalex
- W2146479629 via openalex
- W2146953551 via openalex
- W2155024696 via openalex
- W2160882660 via openalex
- W2162415072 via openalex
- W2163597466 via openalex
- W2204640292 via openalex
- W2262444131 via openalex
- W2288446059 via openalex
- W2291960606 via openalex
- W2324677651 via openalex
- W2395333784 via openalex
Cited by (50)
- Phytochemicals Modulating Receptor Tyrosine Kinase Signaling Networks in Endometriosis 2026
- Estetrol potentiates progesterone-driven growth restraint while blunting pro-angiogenic activation in murine endometriosis lesions 2026
- Adenomyosis and Endometriosis: Two Faces of the Same Disease? 2026
- Using systems biology and drug repositioning approaches to discover FDA-approved drugs candidates for endometriosis treatment 2025
- Vascular endothelial growth factor +405 G/C polymorphism and endometriosis risk: a comprehensive meta-analysis 2025
- Phaleria Macrocarpa Extract Reduced Endometriosis Lesions by Regulating Inflammatory Protein and Inhibiting Ki67 and Vegf-A Protein 2025
- Insights into inflammatory gene expression in endometriosis: a comparative evaluation of tissue biopsy samples 2025
- Impaired decidualization and angiogenesis in eutopic endometrium of endometriosis: insights from in vitro models† 2025
- Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies 2025
- The effect of GnRH-a on the angiogenesis of endometriosis 2024
- Decreased expression of KLF6 in ectopic endometrial stromal cells contributes to endometriosis progression by targeting CTNNB1 2024
- Soluble MICA in endometriosis pathophysiology: Impairs NK cell degranulation and effector functions 2024
- The Sphingosine 1-Phosphate Axis: an Emerging Therapeutic Opportunity for Endometriosis 2023
- Deubiquitinase and unconjugated ubiquitin activate microenvironment inflammation and pain in eutopic and ectopic endometrium in endometriosis 2023
- A Comprehensive Review of the Efficacy and Safety of Dopamine Agonists for Women with Endometriosis-associated Infertility from Inception to July 31, 2022 2023
- Digestive system deep infiltrating endometriosis: What do we know 2023
- The Role of Quercetin for the Treatment of Endometriosis and Endometrial Cancer: A Comprehensive Review 2023
- The Abundance and Function of Neutrophils in the Endometriosis Systemic and Pelvic Microenvironment 2023
- Review of the Potential Therapeutic Effects and Molecular Mechanisms of Resveratrol on Endometriosis 2023
- Global endometrial DNA methylation analysis reveals insights into mQTL regulation and associated endometriosis disease risk and endometrial function 2023
- Global Endometrial DNA Multi-omics Analysis Reveals Insights into mQTL Regulation and Associated Endometriosis Disease Risk 2022
- Endometrial omix marker in patients with endometriosis and pelvic pain: conjugated ubiquitin 2022
- Endometriosis Research: From Bench to Bedside 2022
- Altered gene expression of VEGF, IGFs and H19 lncRNA and epigenetic profile of H19-DMR region in endometrial tissues of women with endometriosis 2022
- Papel de MICA na endometriose 2022
- Inversion of angiogenesis with ethinyl estradiol/dienogest or estradiol valerate/dienogest 2022
- Non-invasive diagnosis of endometriosis: Immunologic and genetic markers 2022
- The Role of the Microenvironment in Endometriosis: Parallels and Distinctions to Cancer 2022
- Telocytes and endometriosis 2022
- Curcumin treats endometriosis in mice by the HIF signaling pathway 2022
- Quinagolide Treatment Reduces Invasive and Angiogenic Properties of Endometrial Mesenchymal Stromal Cells 2022
- Proteostasis and decreased alphaB-crystallin activity in eutopic and ectopic endometrium in patients with endometriosis and chronic pelvic pain 2022
- Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis 2022
- The Impact of Endometriosis on Controlled Ovarian Stimulation Outcome 2022
- Immunosuppression and immunotherapy in endometriosis 2021
- Intermenstrual spotting and angiogenic effects of contraception with a combined hormonal estrogen-gestagenic drug 2021
- Endometriosis diagnosis and medical treatment: Present and future 2021
- Endometriosis - Recent Advances, New Perspectives and Treatments 2021
- Clinical consequences of defective decidualization 2021
- The Relationship between Decorin and VEGF in Endometriosis 2021
- Endometriosis stem cell sources and potential therapeutic targets: literature review and bioinformatics analysis 2021
- The role of the immune system in the pathogenesis of endometriosis 2021
- Small Bowel Obstruction Caused by Ileal Endometriosis with Appendiceal and Lymph Node Involvement Treated with Single-Incision Laparoscopic Surgery: A Case Report and Review of the Literature 2021
- The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions 2021
- Phytochemical characteristics from Phaleria macrocarpa and its inhibitory activity on the peritoneal damage of endometriosis 2020
- Dopamine agonists as genital endometriosis target therapy 2020
- FACTORS OF ENDOMETRIAL RECEPTIVITY DOWN-REGULATION IN GENITAL ENDOMETRIOSIS 2020
- Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies 2020
- Impact of Bevacizumab on Experimentally Induced Endometriotic Lesions: Angiogenesis, Invasion, Apoptosis, and Cell Proliferation 2020
- Use of dopamine agonists to target angiogenesis in women with endometriosis 2020
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:03:58.311020+00:00